Nervgen Pharma Corp (NGEN)
Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2006 | 03-2006 | 12-2005 | 09-2005 | 06-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,070 | -12,020 | -96,490 | -26,810 | -17,970 |
| Depreciation Amortization | 3,070 | 1,340 | 4,870 | 4,190 | 2,900 |
| Other Working Capital | -710 | -670 | -2,320 | -3,960 | -2,260 |
| Other Operating Activity | 3,430 | 1,560 | 59,330 | 60 | -200 |
| Operating Cash Flow | $-20,280 | $-9,790 | $-34,610 | $-26,520 | $-17,530 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -810 | -500 | -1,320 | -1,270 | -920 |
| Net Acquisitions | -5,810 | -5,590 | 0 | -1,680 | -1,680 |
| Other Investing Activity | 13,130 | 6,300 | 6,720 | 22,190 | 23,430 |
| Investing Cash Flow | $6,510 | $210 | $5,400 | $19,240 | $20,830 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 15,950 | 15,860 | 20,080 | 19,550 | 130 |
| Financing Cash Flow | $15,950 | $15,860 | $20,080 | $19,550 | $130 |
| Exchange Rate Effect | -470 | -150 | -50 | 20 | 20 |
| Beginning Cash Position | 6,190 | 6,190 | 15,370 | 15,370 | 15,370 |
| End Cash Position | 7,890 | 12,320 | 6,190 | 27,670 | 18,820 |
| Net Cash Flow | $1,690 | $6,120 | $-9,170 | $12,290 | $3,450 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,280 | -9,790 | -34,610 | -26,520 | -17,530 |
| Free Cash Flow | -20,280 | -9,790 | -34,610 | -26,520 | -17,530 |